Does VELIPARIB Cause Hypomagnesaemia? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Hypomagnesaemia have been filed in association with VELIPARIB. This represents 3.6% of all adverse event reports for VELIPARIB.
14
Reports of Hypomagnesaemia with VELIPARIB
3.6%
of all VELIPARIB reports
1
Deaths
9
Hospitalizations
How Dangerous Is Hypomagnesaemia From VELIPARIB?
Of the 14 reports, 1 (7.1%) resulted in death, 9 (64.3%) required hospitalization, and 3 (21.4%) were considered life-threatening.
Is Hypomagnesaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VELIPARIB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does VELIPARIB Cause?
Neutrophil count decreased (124)
Anaemia (118)
White blood cell count decreased (94)
Febrile neutropenia (76)
Platelet count decreased (70)
Hypertension (57)
Nausea (46)
Hyponatraemia (38)
Vomiting (36)
Hypokalaemia (31)
What Other Drugs Cause Hypomagnesaemia?
OMEPRAZOLE (1,766)
PANTOPRAZOLE (1,246)
PANITUMUMAB (611)
ESOMEPRAZOLE (591)
CARBOPLATIN (586)
LANSOPRAZOLE (504)
FUROSEMIDE (501)
FLUOROURACIL (477)
METFORMIN (415)
CISPLATIN (395)
Which VELIPARIB Alternatives Have Lower Hypomagnesaemia Risk?
VELIPARIB vs VEMURAFENIB
VELIPARIB vs VENETOCLAX
VELIPARIB vs VENLAFAXINE
VELIPARIB vs VENTAVIS
VELIPARIB vs VENTOLIN